EuroPCR: SOURCE Registry one-year mortality rates inform TAVI operators

Justine Varieur Cadet | May 27, 2010 | Cardiovascular Business | Structural Heart Disease

Slideshow | The SOURCE Family of Registries: 1 Year Results from Cohort 1 of the SOURCE Registry

The European Registry of Transcatheter Aortic Valve Implantation using the Edwards SAPIEN Valve

Martyn Thomas, MD, director of cardiothoracic services, Guys and St. Thomas' NHS Foundation Trust in London, reported Tuesday on the one-year mortality rates with transcatheter heart valve implantations with the Sapien valve (Edwards Lifesciences) using either a transfemoral or transapical approach, based on results of 1,038 high-risk patients assessed in the SOURCE Registry at EuroPCR in Paris.

Justine Varieur Cadet

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

EuroPCR: SOURCE Registry one-year mortality rates inform TAVI operators

Related Content

Around the web